Honestly, I was expecting some type of breaking news due to the time this call was announced. It seemed a bit deflating, I won't sugar coat it. I was expecting enrollment to be further along, especially with all of the cases that are currently ongoing. I would prefer Cytodyn to hold off with regurgitating this same information to shareholders next week. Please hold the next cc when you have results. Enrollment, data, FDA feedback. SOMETHING...
And if there is a short attack this morning it's justified. I'm sure there's many others that were expecting the enrollment to be further along as well, shorts will take advantage of those sellers. And I can't blame them.
Don't take this post as dumping on Cytodyn either, please. I'm still holding my position. They have a great product, but poor execution. So their desire to hire more talented personnel is well received and probably the best news that came out of that call...

Good day to everyone,